Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
The United States has once again placed India on its Priority Watch List in the 2024 Special 301 Report, citing ongoing concerns over India's pharmaceutical patent policies, data protection, and enforcement mechanisms. The move underscores a longstanding divide between the two nations over balancing intellectual prope…
Share This Article
Ready-to-post copy includes the article link.
U.S. Maintains India on Priority IP Watch List Amid Ongoing Disputes Over Drug Patents The United States has once again placed India on its Priority Watch List in the 2024 Special 301 Report, citing ongoing concerns over India's pharmaceutical patent policies, data protection, and enforcement mechanisms.... Read the full IIPLA article: https://iipla.org/news/u-s-maintains-india-on-priority-ip-watch-list-amid-ongoing-disputes-over-drug-patents